Donor-specific antibodies adversely affect kidney allograft outcomes.
about
New directions for rabbit antithymocyte globulin (Thymoglobulin(®)) in solid organ transplants, stem cell transplants and autoimmunityFactors influencing long-term outcome after kidney transplantationMemory B cells in transplantationAntithymocyte globulin is associated with a lower incidence of de novo donor-specific antibodies in moderately sensitized renal transplant recipientsEarly acute antibody-mediated rejection of a negative flow crossmatch 3rd kidney transplant with exclusive disparity at HLA-DP.Diagnosis and management of antibody-mediated rejection: current status and novel approaches.Detection of C3d-binding donor-specific anti-HLA antibodies at diagnosis of humoral rejection predicts renal graft loss.HLA sensitisation: can it be prevented?Antibody-Dependent NK Cell Activation Is Associated with Late Kidney Allograft Dysfunction and the Complement-Independent Alloreactive Potential of Donor-Specific AntibodiesA Comparison of Two Types of Rabbit Antithymocyte Globulin Induction Therapy in Immunological High-Risk Kidney Recipients: A Prospective Randomized Control StudyChronic inflammation of the placenta: definition, classification, pathogenesis, and clinical significance.B cells in transplantation.Early and Sustained Reduction in Donor-Specific Antibodies in Desensitized Living Donor Kidney Transplant Recipients: A 3-Year Prospective Study.From Humoral Theory to Performant Risk Stratification in Kidney Transplantation.Endothelial Cells in Antibody-Mediated Rejection of Kidney Transplantation: Pathogenesis Mechanisms and Therapeutic Implications.Antibody-Mediated Rejection: A Review.Nephrectomy for the failed renal allograft in children: predictors and outcomes.The specificity of acute and chronic microvascular alterations in renal allografts.Pretransplant identification of acute rejection risk following kidney transplantation.Immunosuppression and allograft rejection following lung transplantation: evidence to date.The increasing clinical importance of alloantibodies in kidney transplantation.Better understanding of transplant glomerulopathy secondary to chronic antibody-mediated rejection.Simultaneous pancreas and kidney transplantation: current trends and future directions.B-cell biomarkers in transplantation--from genes to therapy.Humoral immunity in renal transplantation: epitopes, Cw and DP, and complement-activating capability--an update.Identifying endpoints to predict the influence of immunosuppression on long-term kidney graft survival.Kidney retransplantation in children following rejection and recurrent disease.Biomarkers in pancreas transplant.Clinical and immunological relevance of antibodies in solid organ transplantation.Long-Term Outcomes in Belatacept- Versus Cyclosporine-Treated Recipients of Extended Criteria Donor Kidneys: Final Results From BENEFIT-EXT, a Phase III Randomized Study.Inter-individual differences in HLA expression can impact the CDC crossmatch.Bortezomib may stabilize pediatric renal transplant recipients with antibody-mediated rejection.Acute Rejection Phenotypes in the Current Era of Immunosuppression: A Single-Center Analysis.The Presence of Anti-Angiotensin II Type-1 Receptor Antibodies Adversely Affect Kidney Graft Outcomes.Diagnosis and Treatment of Pancreas Rejection.False-positive reactions against HLA class II molecules detected in Luminex single-antigen bead assays.Development of immune response to tissue-restricted self-antigens in simultaneous kidney-pancreas transplant recipients with acute rejection.Accelerated rejection, thrombosis, and graft failure with angiotensin II type 1 receptor antibodies.Impact of Preformed Donor-Specific Anti-Human Leukocyte Antigen Antibody C1q-Binding Ability on Kidney Allograft Outcome.Clinical Significance of Pretransplant Donor-Specific Antibodies in the Setting of Negative Cell-Based Flow Cytometry Crossmatching in Kidney Transplant Recipients.
P2860
Q26823090-E90FCF2A-B258-42CD-BC69-89091CB8EA8EQ26825480-13A2C44B-8E5F-4C9C-8511-A3F74CDC40FEQ26829296-195F4658-4392-448F-ADDF-3F90454E0FE7Q33930084-55EBE771-D3D3-4570-81FE-F9AF06ED88B2Q33993707-9F0A00B6-81E4-4E86-B920-70FDD4F6B3D3Q34841849-DEBC9FDC-4D25-483F-8D43-EE1484D15B9BQ35027253-7161F9D2-F9D8-4CAD-8C9C-18031095AF5AQ35097898-677B3622-2337-4468-B0F5-3B575CBC67C1Q36113914-61AEBFFF-23E9-4943-8739-7AE5BE1CF15DQ36194995-336BDE51-453A-46F0-BC55-B69DBD4CD5CAQ36663036-52598345-FBEB-4D5F-A024-4490933CAFAEQ37029874-D3EC4F3E-7C54-41C8-8291-52996AF7ACE0Q37097768-3D8D9450-E154-42CB-94C6-0C5DEBDA3D25Q37590820-FED4928B-0D5E-42BB-B925-E677A198DF2CQ37642331-D01D2043-4EB7-4EF1-91D7-AAC04E2880F8Q37698860-66E6E127-9256-43CB-9301-8D578E48117EQ38100687-09813559-5B1F-44CF-B41B-024999DC9C11Q38151921-F2EE1F68-BB6C-4EBA-A1D6-069C7B928F63Q38151922-2812F2C1-71F2-4296-9355-F8F2294ADC02Q38154197-E85DBD5F-1212-4F58-8624-03BEEE522CAAQ38258153-12A5BA64-C8F0-419D-AC7A-F4EFE64CC128Q38282840-F9FB5FE8-9898-47AF-9E88-8CE2A2CCF19CQ38309889-11F7D695-A818-43E2-915A-A7AE1052321FQ38334458-1D589E3A-D986-45CE-B1FC-5EFFBDB03535Q38341785-1A24FC15-72B4-47C6-975B-30C4A2C9491DQ38429887-605B8254-8A6E-427B-B87C-90C39B524567Q38798905-90FA8933-ADDC-4CEF-BED5-822451466140Q38848032-5B83A087-E4B8-481B-8A58-290FA41F03C9Q39015291-811333AB-99D4-4448-BAD8-1EDB9A9578CCQ39808031-FD8A3059-D37F-445D-ACA5-7AF07ED89C15Q41197451-DC236A97-65BF-4B62-8C78-0DB8FBAD6637Q41495990-0C541BE8-EA1D-4179-80FA-B6D518A671C2Q41946081-B866C99D-820F-4124-9A31-77E4CBD3BB16Q42233729-E47E50C8-E1EA-45AE-A9B1-76EEA6053E2CQ42554733-BCCFBBDE-FBC7-4392-A115-433D77A3E21AQ42854881-5F40EB62-CBB6-49F7-AA83-EAB9544FE64AQ45982490-0FDBF022-F0F2-40E9-849E-90ABCB4D0BB4Q46456694-70D2FFC8-31AC-49DB-AB45-1B54F66755E4Q47130649-5130CFB7-62FF-4EFA-BDFB-D0C3E270DF69Q47313617-B8E9184D-E541-4C58-97C2-7F991719DD95
P2860
Donor-specific antibodies adversely affect kidney allograft outcomes.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Donor-specific antibodies adversely affect kidney allograft outcomes.
@ast
Donor-specific antibodies adversely affect kidney allograft outcomes.
@en
type
label
Donor-specific antibodies adversely affect kidney allograft outcomes.
@ast
Donor-specific antibodies adversely affect kidney allograft outcomes.
@en
prefLabel
Donor-specific antibodies adversely affect kidney allograft outcomes.
@ast
Donor-specific antibodies adversely affect kidney allograft outcomes.
@en
P2093
P2860
P31
P356
P1476
Donor-specific antibodies adversely affect kidney allograft outcomes
@en
P2093
Amudha Palanisamy
Bekir Tanriover
David J Cohen
Demetra Tsapepas
Geoffrey Dube
Jai Radhakrishnan
Lloyd E Ratner
R John Crew
P2860
P304
P356
10.1681/ASN.2012070664
P50
P577
2012-11-15T00:00:00Z